You are here: Industry Insights > Market News > Three-fold increase in remdesivir production in India: Mansukh Mandaviya

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

Avatrombopag Maleate

BioHub® Magnetic Separator

Avatrombopag

Ursodeoxycholic acid

Troxerutin

CytoLinX® BRTF Single-use Top-driven Bioreactor Bag

Three-fold increase in remdesivir production in India: Mansukh Mandaviya

expresspharmaMay 07, 2021

Tag: Remdesivir , Mansukh Mandaviya , India

Favorites

The production of remdesivir is being increased at a rapid pace in the country. In just a few days, India has achieved three times the production capacity of the medicine, and will soon be able to meet the growing demand, informed Mansukh Mandaviya, Minister of State for Chemical and Fertilizers via Twitter yesterday.

He also wrote, “In view of the increase in demand, the number of plants producing remdesivir has also gone up from 20 on 12th April, 2021 to 57 on 4th May, 2021.”

Further, the production has gone up from 37 lakh on 12th April, 2021 to 1.05 crore on 4th May, 2021, according to a statement by Ministry of Chemicals and Fertilizers.

Previous:RBI announces on-tap liquidity window of Rs 50,000 cr for healthcare infra, services firms

Next:MoHF&W issues guidelines for COVID-19 vaccine import by private sector

Sartorius Stedim Biotech Opens New Center for Bioprocess Innovation in Marlborough, USA

PharmaSourcesNovember 22, 2024

Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, today opened its new Center for Bioprocess Innovation in Marlborough, Massachusetts.

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Biotech NewswireNovember 20, 2024

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

PR NEWSWIRENovember 20, 2024

Three-fold increase in remdesivir production in India: Mansukh Mandaviya | Pharmasources.com

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

Nurah EkhlaqueNovember 19, 2024

Discover how AI in pharmacovigilance improves drug safety by predicting risks, identifying harmful interactions, and enhancing patient outcomes.

Three-fold increase in remdesivir production in India: Mansukh Mandaviya

Related News

Sartorius Stedim Biotech Opens New Center for Bioprocess Innovation in Marlborough, USA

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

You may like
More>>

Three-fold increase in remdesivir production in India: Mansukh Mandaviya

Related News

Sartorius Stedim Biotech Opens New Center for Bioprocess Innovation in Marlborough, USA

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

You may likeMore>>

You may like
More>>